Institutional Ownership
Global Blood Therapeutics In
CUSIP 37890U108COMGBTUSDQ1 2026
13D / 13G Filings
30
Schedule 13D/13G on record
Beneficial Filers
11
Distinct reporting persons
Largest Stake
11.0%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
30 filings · latest Feb 14, 2023
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 14, 2023 | Deep Track Capital, LP | 13G/A | — | — | SEC |
| 2 | Feb 9, 2023 | Fmr LLC | 13G/A | 0.4% | — | SEC |
| 3 | Jun 17, 2022 | Deep Track Capital, LP | 13G | 5.6% | 3.65M | SEC |
| 4 | Feb 14, 2022 | Perceptive Advisors LLC | 13G/A | 5.4% | 3.45M | SEC |
| 5 | Feb 14, 2022 | Baker Bros. Advisors LP | 13G | 5.1% | 3.31M | SEC |
| 6 | Feb 14, 2022 | Point72 Asset Management, L.P. | 13G/A | 0.3% | 183.5K | SEC |
| 7 | Feb 14, 2022 | Price T Rowe Associates Inc /Md/ | 13G/A | 5.0% | 3.26M | SEC |
| 8 | Feb 10, 2022 | Janus Henderson Group PLC | 13G/A | 8.5% | 5.48M | SEC |
| 9 | Feb 10, 2022 | Vanguard Group Inc | 13G/A | 9.3% | 5.99M | SEC |
| 10 | Feb 9, 2022 | Fmr LLC | 13G | 7.1% | — | SEC |
20 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Global Blood Therapeutics In.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Huntington National Bank | 1 | $68 |